Patents by Inventor Natasha Louise Tilston-Lunel

Natasha Louise Tilston-Lunel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Measles virus vaccine expressing SARS-CoV-2 protein(s)
    Patent number: 11298417
    Abstract: A recombinant measles viral vector comprising a nucleic acid sequence encoding a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike glycoprotein is provided. Polypeptides comprising the SARS-CoV-2 spike glycoprotein also are provided, as well as related nucleic acids, vectors, and compositions. The polypeptides, nucleic acids, vectors, and compositions can be used in methods of preventing, inhibiting, reducing, eliminating, protecting, or delaying the onset of an infection or an infectious clinical condition caused by coronavirus and methods for inducing an immune response against a coronavirus.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: April 12, 2022
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: William Paul Duprex, Natasha Louise Tilston-Lunel, Shamkumar Nambulli